Bridging the gap: large animal models in neurodegenerative research

Mammalian Genome

Volumn 28, Issue 7-8, 2017, Pages 324-337

  Eaton, S L ^a   Wishart, T M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA TELANGIECTASIA; DEGENERATIVE DISEASE; DISEASE MODEL; DOG; DUCHENNE MUSCULAR DYSTROPHY; GENETIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; LYSOSOME STORAGE DISEASE; MEDICAL RESEARCH; MONOGENETIC DISORDER; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PARKINSON DISEASE; PIG; POLYGENETIC DISORDER; PRIMATE; PRION DISEASE; REVIEW; RODENT; SHEEP; ANIMAL; GENETIC PREDISPOSITION; METABOLISM; NEUROLOGIC DISEASE; RESEARCH; TRANSGENIC ANIMAL; WORKFLOW;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; RESEARCH; WORKFLOW;

EID: 85017109840     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-017-9687-6     Document Type: Review

References (70)

1. Amorim IS et al (2015) Molecular neuropathology of the synapse in sheep with CLN5 Batten disease. Brain Behav 5(11):e00401. doi:10.1002/brb3.401
2. Barlow C et al (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86(1):159–171
3. Beale AM et al (1989) “MPTP-induced Parkinson-like disease in sheep: clinical and pathologic findings”. J Environ Pathol Toxicol Oncol 9(5–6):417–428
4. Beck SE et al (2015) Paving the path to HIV neurotherapy: Predicting SIV CNS disease. Eur J Pharmacol 759:303–312
5. Beraldi R et al (2015) A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Hum Mol Genet 24(22):6473–6484
6. Bible E et al (2004) Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16(2):346–359
7. Bowen A, Casadevall A (2015) Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research. Proc Natl Acad Sci USA 112(36):11335–11340
8. Carryl H, et al (2015). Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? ACS Chem Neurosci 6(8):1276–1289
9. Chahroudi A et al (2014) Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques. PLoS Pathog 10(3):e1003958
10. Chang R et al (2015) Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy. Drug Des Dev Ther 9:2179–2188
11. Checchi M et al (2016) Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors. Vox Sang 111(4):325–332
12. Chouraki V, Seshadri S (2014) Genetics of Alzheimer’s disease. Adv Genet 87:245–294
13. Dawson TM et al (2010) Genetic animal models of Parkinson’s disease. Neuron 66(5):646–661
14. Dezzutti CS (2015) Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success? J Int AIDS Soc 18:20301
15. Dolezalova D et al (2014) Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies. J Comp Neurol 522(12):2784–2801
16. Duque SI et al (2015) A large animal model of spinal muscular atrophy and correction of phenotype. Ann Neurol 77(3):399–414
17. Elbirt D et al (2015) HIV-associated neurocognitive disorders (HAND). Isr Med Assoc J 17(1):54–59
18. Emborg ME (2007) Nonhuman primate models of Parkinson’s disease. ILAR J 48(4):339–355
19. Foster J, Hunter N (1998) Transmissible spongiform encephalopathies: transmission, mechanism of disease, and persistence. Curr Opin Microbiol 1(4):442–447
20. Frohna PA et al (1995) Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse 19(1):46–55
21. Fuller HR et al (2016) Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation. Expert Rev Proteomics 13(7):659–671
22. Garner JP (2014) The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?” ILAR J 55(3):438–456
23. Geraets RD, et al (2016) Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Orphanet J Rare Dis 11:40
24. Greek R, Menache A (2013) Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci 10(3):206–221
25. Grow DA et al (2016) Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson’s disease. Stem Cell Res 17(2):352–366
26. Hall VJ et al (2015) Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig. Dis Model Mech 8(10):1265–1278
27. Heuer E et al (2012) Nonhuman primates of Alzheimer-like cerebral proteopathy. Curr Pharm Des 18(8):1159–1169
28. Holm IE et al (2016) Genetically modified pig models for neurodegenerative disorders. J Pathol 238(2):267–287
29. Houston F et al (2008)“Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112(12):4739–4745
30. Howland DS, Munoz-Sanjuan I (2014) Mind the gap: models in multiple species needed for therapeutic development in Huntington’s disease. Mov Disord 29(11):1397–1403
31. Hunter N et al (2002) Transmission of prion diseases by blood transfusion. J Gen Virol 83(Pt 11):2897–2905
32. Hunter G et al (2016) Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. Hum Mol Genet 25(13):2853–2861
33. Jackson WS et al (2013) Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases. Proc Natl Acad Sci USA 110(36):14759–14764
34. Jagmag SA et al (2015) Evaluation of Models of Parkinson’s Disease. Front Neurosci 9:503
35. Keifer J, Summers CH (2016) Putting the “Biology” Back into “Neurobiology”: The Strength of Diversity in Animal Model Systems for Neuroscience Research. Front Syst Neurosci 10:69
36. Li XJ, Li S (2012) Influence of species differences on the neuropathology of transgenic Huntington’s disease animal models. J Genet Genom 39(6):239–245
37. Lorenzen E et al (2015) A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection. Vet Res 46:116
38. McGreevy JW et al (2015) “Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy”. Dis Model Mech 8(3):195–213
39. Mikkelsen M et al (1999) MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study. Neurotoxicol Teratol 21(2):169–175
40. Morton AJ, Avanzo L (2011) Executive decision-making in the domestic sheep”. PLoS ONE 6(1):e15752
41. Morton AJ et al (2013) Early and progressive circadian abnormalities in Huntington’s disease sheep are unmasked by social environment. Hum Mol Genet 23(13):3375–3383
42. Moser JM et al (2013) The wobbler mouse, an ALS animal model. Mol Genet Genom 288(5–6):207–229
43. Mutsaers CA et al (2013) Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy. Genome Med 5(10):95
44. Palmer DN et al (2015) Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network. Biochim Biophys Acta 1852(10 Pt B):2279–2286
45. Park, K. H. (2015). Mechanisms of muscle denervation in aging: insights from a mouse model of amyotrophic lateral sclerosis. Aging Dis 6(5):380–389
46. Peeters M, Delaporte E (2012) Simian retroviruses in African apes. Clin Microbiol Infect 18(6):514–520
47. Philips T, Rothstein JD (2015) Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol 69:5.67.1–5.67.21. doi:10.1002/0471141755.ph0567s69
48. Pinnapureddy AR et al (2015) Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease. Orphanet J Rare Dis 10:107
49. Δex7/8 knock-in mouse model of Batten disease. Neurobiol Dis 20(3):823–836
50. Pouladi MA et al (2013) Choosing an animal model for the study of Huntington’s disease. Nat Rev Neurosci 14(10):708–721
51. Price DL et al (1998) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282(5391):1079–1083
52. Rae MG, O’Malley D (2016). Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. 116(3):1304–1315
53. Ramaswamy S et al (2007) Animal models of Huntington’s disease. ILAR J 48(4):356–373
54. Saito T et al (2014) Single App knock-in mouse models of Alzheimer’s disease. Nat Neurosci 17(5):661–663
55. Schook LB et al (2015) Unraveling the swine genome: implications for human health. Annu Rev Anim Biosci 3:219–244
56. Siso S et al (2012) Disease phenotype in sheep after infection with cloned murine scrapie strains. Prion 6(2):174–183
57. Stanzione P, Tropepi D (2011) Drugs and clinical trials in neurodegenerative diseases. Ann Ist Super Sanita 47(1):49–54
58. Toledano A et al (2012) Does Alzheimer’s disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications. Neurologia 27(6):354–369
59. van Vliet D et al (2013) Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychol Med 43(2):423–432
60. Wang X, et al (2016) One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system. Sci Rep 6:20620
61. Weber K, Pearce DA (2013) Large animal models for Batten disease: a review. J Child Neurol 28(9):1123–1127
62. Whitelaw CB et al (2016) Engineering large animal models of human disease. J Pathol 238(2):247–256
63. Wishart TM et al (2012) Combining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivo. PLoS Genet 8(8):e1002936
64. Wishart TM et al (2014) Dysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy. J Clin Invest 124(4):1821–1834
65. Yang D et al (2010) Expression of Huntington’s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet 19(20):3983–3994
66. Yang H et al (2014) Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res 24(4):464–481
67. Yang J et al (2016) Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity. Neurosci Lett 611:51–58
68. Yap PL et al (1998) Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives. Vox Sang 74(Suppl 2):131–134
69. Yun JW et al (2015) Modeling Parkinson’s disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care. Lab Anim Res 31(4):155–165
70. Zahs KR, Ashe KH (2015) More than a FAD: the in vivo effects of disease-linked presenilin-1 mutations. Neuron 85(5):893–895